Biomedical Engineering Reference
In-Depth Information
84. Hornof M, de la FM, Hallikainen M, Tammi RH, Urtti A (2008) Low molecular weight
hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in
human corneal epithelial cells. J Gene Med 10:70-80
85. Ito T, Yoshihara C, Hamada K, Koyama Y (2010) DNA/polyethyleneimine/hyaluronic acid
small complex particles and tumor suppression in mice. Biomaterials 31:2912-2918
86. Kurosaki T, Kitahara T, Fumoto S, Nishida K, Nakamura J, Niidome T, Kodama Y,
Nakagawa H, To H, Sasaki H (2009) Ternary complexes of pDNA, polyethylenimine, and
gamma-polyglutamic acid for gene delivery systems. Biomaterials 30:2846-2853
87. Kurosaki T, Kitahara T, Kawakami S, Higuchi Y, Yamaguchi A, Nakagawa H, Kodama Y,
Hamamoto T, Hashida M, Sasaki H (2010) Gamma-polyglutamic acid-coated vectors for
effective and safe gene therapy. J Control Release 142:404-410
88. Kircheis R, Wightman L, Schreiber A, Robitza B, Rossler V, Kursa M, Wagner E (2001)
Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors
after systemic application. Gene Ther 8:28-40
89. Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature:
the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul
41:189-207
90. Wagner E, Culmsee C, Boeckle S (2005) Targeting of polyplexes: toward synthetic virus
vector systems. Adv Genet 53:333-354
91. Hughes JA, Rao GA (2005) Targeted polymers for gene delivery. Expert Opin Drug Deliv
2:145-157
92. Boeckle S, Wagner E (2006) Optimizing targeted gene delivery: chemical modification of
viral vectors and synthesis of artificial virus vector systems. AAPS J 8:E731-E742
93. Russ V, Wagner E (2007) Cell and tissue targeting of nucleic acids for cancer gene therapy.
Pharm Res 24:1047-1057
94. Philipp A, Meyer M, Wagner E (2008) Extracellular targeting of synthetic therapeutic nucleic
acid formulations. Curr Gene Ther 8:324-334
95. Wagner E, Curiel D, Cotten M (1994) Delivery of drugs, proteins and genes into cells using
transferrin as a ligand for receptor-mediated endocytosis. Adv Drug Del Rev 14:113-136
96. Cotten M, Langle-Rouault F, Kirlappos H, Wagner E, Mechtler K, Zenke M, Beug H,
Birnstiel ML (1990) Transferrin-polycation-mediated introduction of DNA into human
leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate
transferrin receptor levels. Proc Natl Acad Sci USA 87:4033-4037
97. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML (1990) Transferrin-polycation
conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 87:3410-3414
98. Zenke M, Steinlein P, Wagner E, Cotten M, Beug H, Birnstiel ML (1990) Receptor-mediated
endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into
hematopoietic cells. Proc Natl Acad Sci USA 87:3655-3659
99. Wagner E, Cotten M, Mechtler K, Kirlappos H, Birnstiel ML (1991) DNA-binding transferrin
conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium
homodimer to the transferrin carbohydrate moiety. Bioconjug Chem 2:226-231
100. Kircheis R, Kichler A, Wallner G, Kursa M, Ogris M, Felzmann T, Buchberger M, Wagner E
(1997) Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene
Ther 4:409-418
101. Bellocq NC, Pun SH, Jensen GS, Davis ME (2003) Transferrin-containing, cyclodextrin
polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 14:1122-1132
102. Pons B, Mouhoubi L, Adib A, Godzina P, Behr JP, Zuber G (2006) omega-Hydrazino
linear polyethylenimine: a monoconjugation building block for nucleic acid delivery.
Chembiochem 7:303-309
103. Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, Jiang C (2007) Efficient gene delivery targeted
to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine
dendrimer. FASEB J 21:1117-1125
